ATE216226T1 - Verwendung von sorbitol-dehydrogenase-inhibitoren zum reduzieren von ischämie-assozierten gewebeschäden - Google Patents
Verwendung von sorbitol-dehydrogenase-inhibitoren zum reduzieren von ischämie-assozierten gewebeschädenInfo
- Publication number
- ATE216226T1 ATE216226T1 AT97200415T AT97200415T ATE216226T1 AT E216226 T1 ATE216226 T1 AT E216226T1 AT 97200415 T AT97200415 T AT 97200415T AT 97200415 T AT97200415 T AT 97200415T AT E216226 T1 ATE216226 T1 AT E216226T1
- Authority
- AT
- Austria
- Prior art keywords
- tissue damage
- sorbitol dehydrogenase
- dehydrogenase inhibitors
- associated tissue
- reduce ischemia
- Prior art date
Links
- 208000028867 ischemia Diseases 0.000 title abstract 2
- 230000000451 tissue damage Effects 0.000 title abstract 2
- 231100000827 tissue damage Toxicity 0.000 title abstract 2
- 108010009384 L-Iditol 2-Dehydrogenase Proteins 0.000 title 1
- 102100026974 Sorbitol dehydrogenase Human genes 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 229940123659 Sorbitol dehydrogenase inhibitor Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1270896P | 1996-02-29 | 1996-02-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE216226T1 true ATE216226T1 (de) | 2002-05-15 |
Family
ID=21756305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97200415T ATE216226T1 (de) | 1996-02-29 | 1997-02-13 | Verwendung von sorbitol-dehydrogenase-inhibitoren zum reduzieren von ischämie-assozierten gewebeschäden |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5932581A (de) |
| EP (1) | EP0791355B1 (de) |
| JP (1) | JPH09316004A (de) |
| KR (1) | KR100219972B1 (de) |
| CN (1) | CN1165000A (de) |
| AT (1) | ATE216226T1 (de) |
| AU (1) | AU714038B2 (de) |
| CA (1) | CA2198536C (de) |
| DE (1) | DE69711965T2 (de) |
| DK (1) | DK0791355T3 (de) |
| ES (1) | ES2174176T3 (de) |
| IL (1) | IL120271A (de) |
| MY (1) | MY118982A (de) |
| PT (1) | PT791355E (de) |
| ZA (1) | ZA971715B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20020005653A (ko) * | 1999-04-01 | 2002-01-17 | 실버스타인 아써 에이. | 소르비톨 디하이드로게나제 저해제로서의 아미노피리미딘 |
| US6825198B2 (en) * | 2001-06-21 | 2004-11-30 | Pfizer Inc | 5-HT receptor ligands and uses thereof |
| CN104346404B (zh) * | 2013-08-08 | 2018-05-18 | 华为技术有限公司 | 一种访问数据的方法、设备及系统 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3905364A1 (de) | 1989-02-22 | 1990-08-23 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool |
| DE4025387A1 (de) | 1990-08-10 | 1992-02-13 | Hoechst Ag | Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als reagenzien |
| WO1994007867A1 (en) | 1992-09-28 | 1994-04-14 | Pfizer Inc. | Substituted pyrimidines for control of diabetic complications |
-
1997
- 1997-02-13 ES ES97200415T patent/ES2174176T3/es not_active Expired - Lifetime
- 1997-02-13 AT AT97200415T patent/ATE216226T1/de not_active IP Right Cessation
- 1997-02-13 DK DK97200415T patent/DK0791355T3/da active
- 1997-02-13 PT PT97200415T patent/PT791355E/pt unknown
- 1997-02-13 DE DE69711965T patent/DE69711965T2/de not_active Expired - Fee Related
- 1997-02-13 EP EP97200415A patent/EP0791355B1/de not_active Expired - Lifetime
- 1997-02-20 US US08/803,302 patent/US5932581A/en not_active Expired - Fee Related
- 1997-02-20 IL IL12027197A patent/IL120271A/en not_active IP Right Cessation
- 1997-02-25 JP JP9040466A patent/JPH09316004A/ja active Pending
- 1997-02-26 CA CA002198536A patent/CA2198536C/en not_active Expired - Fee Related
- 1997-02-27 KR KR1019970006295A patent/KR100219972B1/ko not_active Expired - Fee Related
- 1997-02-27 ZA ZA971715A patent/ZA971715B/xx unknown
- 1997-02-27 MY MYPI97000795A patent/MY118982A/en unknown
- 1997-02-28 AU AU15009/97A patent/AU714038B2/en not_active Ceased
- 1997-02-28 CN CN97103411A patent/CN1165000A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2198536C (en) | 2000-06-20 |
| JPH09316004A (ja) | 1997-12-09 |
| AU714038B2 (en) | 1999-12-16 |
| CA2198536A1 (en) | 1997-08-29 |
| MX9701527A (es) | 1998-06-30 |
| AU1500997A (en) | 1997-09-04 |
| DK0791355T3 (da) | 2002-06-17 |
| IL120271A (en) | 2001-06-14 |
| EP0791355B1 (de) | 2002-04-17 |
| DE69711965D1 (de) | 2002-05-23 |
| KR970061257A (ko) | 1997-09-12 |
| CN1165000A (zh) | 1997-11-19 |
| US5932581A (en) | 1999-08-03 |
| EP0791355A1 (de) | 1997-08-27 |
| ZA971715B (en) | 1998-08-27 |
| ES2174176T3 (es) | 2002-11-01 |
| MY118982A (en) | 2005-02-28 |
| KR100219972B1 (ko) | 1999-09-01 |
| IL120271A0 (en) | 1997-06-10 |
| PT791355E (pt) | 2002-08-30 |
| DE69711965T2 (de) | 2003-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI894748A7 (fi) | Uusia peptidaasi-inhibiittoreita | |
| EA200101166A1 (ru) | Ингибиторы металлопротеаз | |
| FI971412L (fi) | Peptididyyliyhdisteet ja niiden terapeuttinen käyttö metalloproteaasien estäjinä | |
| ATE216239T1 (de) | Verwendung eines aldose-reduktase-inhibitors zur verminderung nicht-kardiologischer gewebeschäden | |
| DE69824183D1 (de) | N-alkanoylphenylalaninderivate | |
| FI961976A7 (fi) | Peptidyyliyhdisteitä ja niiden terapeuttinen käyttö metalloproteinaasien inhibiittoreina | |
| NZ335981A (en) | Ketobenzamides as calpain inhibitors | |
| ES2090244T3 (es) | Procedimiento para prevenir, estabilizar u ocasionar la regresion de la aterosclerosis usando una combinacion de un medicamento para disminuir el colesterol y un inhibidor de la ace. | |
| AR004348A1 (es) | Reduccion del crecimiento del cabello | |
| ATE199545T1 (de) | Inhibitoren retroviraler proteasen | |
| NZ331484A (en) | Serine protease inhibitors having an alkynylamino side chain for use in treatment of thrombin related diseases | |
| TR200101120T2 (tr) | Serin proteaz inhibitörü | |
| PL349511A1 (en) | Utilization of inhibitors of the kqt1 channel in order to produce a medicament for treating diseases which are caused by parasitic helminths and ectoparasites | |
| NO911459D0 (no) | Anvendelse av metallion-komplekser som belegginhibitorer. | |
| DE69711965D1 (de) | Verwendung von Sorbitol-Dehydrogenase-Inhibitoren zum Reduzieren von Ischämie-assozierten Gewebeschäden | |
| SE0301883D0 (sv) | New use II | |
| AR004330A1 (es) | Uso de inhibidores de colinesterasa en el tratamiento de xerostomia | |
| CO5021190A1 (es) | Agentes terapeuticos | |
| PT878195E (pt) | Utilizacao de um composto 2-aroil-3-arilbenzo(b)tiofeno para a reducao de fibrinogenio | |
| ES2173158T3 (es) | Reduccion del tejido adiposo utilizando colagenasa | |
| ATE296345T1 (de) | Verwendung eines kristallwachstumsinhibitors zur verminderung der abreibung von geweben | |
| NO912517D0 (no) | Fremgangsmaate for forlengelse av brukstiden for belegginhibitorer injisert i en formasjon. | |
| FI970807L (fi) | Tiosemikarbatsidien käyttö lahonestoaineina | |
| KR940018986U (ko) | 질감염 치료용 템포 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |